Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04724967 · ClinicalTrials.gov registry record · Phase 4
CeraVe Diabetes Mellitus
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 528
- Enrollment target
NCT04724967: Completed Phase 4 study, sponsored by University of Miami.
NCT04724967 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 528 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04724967, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 528 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the CeraVe Diabetic Skin Line for the improvement of skin condition in patients with diabetes mellitus.
Primary Outcome
As evaluated by treating physician as possibly or probably related to intervention
Interventions
- DRUG CeraVe Hydrating Cleanser
- DRUG CeraVe Moisturizing Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 528 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2021-08-10 |
| Phase | Phase 4 |
What the finished NCT04724967 record still lists
NCT04724967 is an interventional study that assigns participants to a tested intervention. The registered 528 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which CeraVe Hydrating Cleanser is the first listed.
NCT04724967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04724967 about?
NCT04724967 is a clinical study titled "CeraVe Diabetes Mellitus". The purpose of this study is to evaluate the safety and efficacy of the CeraVe Diabetic Skin Line for the improvement of skin condition in patients with diabetes mellitus.
What is the current status of trial NCT04724967?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 528 participants. The study started on 2021-03-12. Estimated completion is 2021-08-10.
What interventions are being tested in trial NCT04724967?
The interventions under investigation include: CeraVe Hydrating Cleanser (DRUG), CeraVe Moisturizing Cream (DRUG).
Who is sponsoring clinical trial NCT04724967?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04724967's enrollment target sits among peer trials
528 157th of 2000 higher than 1,844 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373017 · 528 participants · NA
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
- NCT05634252 · 528 participants · Phase 3
Undergraduate Skin Cancer Prevention Trial
- NCT06383273 · 528 participants · Phase 3
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
- NCT06470243 · 528 participants · Phase 3
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI